Research Article

The Trabecular Bone Score as a Predictor for Thalassemia-Induced Vertebral Fractures in Northeastern Thailand

Table 1

Baseline characteristics of 86 patients with thalassemia.

CharacteristicsTransfusion-dependent thalassemia (TDT) (n = 57)Non-transfusion-dependent thalassemia (NTDT) (n = 29)

Mean age (min-max), years30.5 (18–60)35.5 (18–58)
Mean pretransfused Hb (min-max), g/dL7.2 (4.9–8.8)7.6 (7.5–9.2)
Mean serum ferritin (min-max), ng/mL2.690 (153–11,810)1.651 (336–7,869)
Z-score BMD (min-max), g/cm20.7 (0.4–1.0)0.8 (0.5–1.0)
TBS score (min-max)1.2 (0.8–1.5)1.3 (0.8–1.4)
Gender, n (%)
 Female38 (66.6)14 (48.3)
 Male19 (33.4)15 (51.7)
Splenectomy, n (%)
 No22 (38.6)25 (86.2)
 Yes35 (61.4)4 (13.8)
Vertebral fractures, n (%)
 No48 (84.2)26 (89.6)
 Yes11 (15.8)3 (10.4)
Low lumbar spine BMD, n (%)
 No30 (52.6)20 (68.9)
 Yes27 (47.4)9 (31.1)
Low TBS, n (%)
 No53(93)26 (89.6)
 Yes4 (7)3 (10.4)
Smoking, n (%)
 No51 (89.4)23 (79.3)
 Yes6 (10.6)6 (20.7)
Menopause, n (%)
 No46 (80.7)25 (86.2)
 Yes11 (19.3)4 (13.8)
Endocrinopathies, n (%)
 No44 (77.2)24 (82.7)
 Yes13 (22.8)5 (17.3)
Phenotype group, n (%)
β-thalassemia/Hb E52 (91.2)15 (51.7)
 Homozygous β-thalassemia3 (5.2)0 (0)
 Hb H disease0 (0)5 (17.2)
 Hb H disease with Hb CS0 (0)5 (17.2)
 EABart’s disease2 (3.6)4 (13.9)

Hb CS = hemoglobin constant spring; compound heterozygous Hb H and heterozygous Hb E.